Sonoma Pharmaceuticals
SNOA
#10906
Rank
HK$54.05 M
Marketcap
HK$11.30
Share price
15.20%
Change (1 day)
-52.97%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2026 (TTM): -HK$19.25 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are HK$19.52 Million. In 2025 the company made an earning of -HK$21.7 Million, an increase over its 2024 earnings that were of -HK$35.01 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$19.25 Million-11.3%
2025 -HK$21.7 Million-38.02%
2024 -HK$35.01 Million0.54%
2023 -HK$34.83 Million-31.5%
2022 -HK$50.84 Million16.86%
2021 -HK$43.5 Million194.32%
2020 -HK$14.78 Million-58.76%
2019 -HK$35.84 Million-65.66%
2018 -HK$0.11 Billion4.84%
2017 -HK$99.55 Million-2.17%
2016 -HK$0.11 Billion32.12%
2015 -HK$77.02 Million-307.74%
2014 HK$37.07 M-197.5%
2013 -HK$38.03 Million
2010 -HK$59.42 Million-14.02%
2009 -HK$69.1 Million-57.28%
2008 -HK$0.17 Billion-8.03%
2007 -HK$0.18 Billion3.85%
2006 -HK$0.17 Billion39.31%
2005 -HK$0.13 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-HK$1.8 Billion 9,202.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$0.15 Billion 637.75%๐Ÿ‡บ๐Ÿ‡ธ USA